Pittcon 2025 is Underway!
YMC America is excited to be presenting and exhibiting at Pittcon 2025 in Boston. We have poster presentations and talks by both J Preston, PhD, and Zeshan Aqeel, including;
- Analyzing Charge Heterogeneity in Monoclonal Antibodies and Fusion Proteins via SCX-HPLC
- Reverse Phase Liquid Chromatography Starting with 100% Aqueous Mobile Phases for Higher Polar Molecules
- Analysis of Gingerols using HPLC from Commercially Available Food and Nutraceutical Products
Here’s a brief overview from our Principal Scientist, Applicatons, Zeshan Aqeel.
Previous Article
YMC America Supports the Tournament of Roses Parade Related Posts
September 21, 2026
Join us for our upcoming webinar titled Peptide Purification: From HPLC Origins to Process Intensification
This presentation explores the evolution of peptide purification, from the early days of reversed-phase HPLC to today’s large-scale manufacturing challenges. It covers practical strategies for preparative method development, stationary phase selection, and efficient scale-up, illustrated by a case study on tirzepatide purification. The session also introduces continuous chromatography using MCSGP technology and highlights its potential for process intensification in modern peptide manufacturing.
September 4, 2026
YMC America Brings U.S.-Supplied ASME U-Stamped DAC Columns to Pharmaceutical Manufacturers
YMC America will be the First U.S.-Based Supplier of ASME U-Stamped DAC Columns.
The company’s DAC columns support pharmaceutical and biopharmaceutical customers from process development through commercial production. Systems are used in laboratory, pilot, and production-scale chromatography applications, including purification processes for peptides, oligonucleotides, and small-molecule APIs.
September 10, 2026
Analytical Technologies for Therapeutic Peptides
Therapeutic peptides are an emerging class of active pharmaceutical ingredients that, together with other classes of bioproducts, have been attracting considerable attention due to their unique advantages. Their structure is based on well-defined amino acid sequences that may or may not contain structural modifications, resulting in molecules that generally range from 500 to 5000 Da. Currently, many examples can be used as medicines related to hormones, growth factors, neurotransmitters, among others.
